David J. Donnelly
State University of New York System
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David J. Donnelly.
Biochemistry | 2008
Gregory Tombline; Jason J. Holt; Michael K. Gannon; David J. Donnelly; Bryan Wetzel; Geri A. Sawada; Thomas J. Raub; Michael R. Detty
The multidrug efflux pump P-glycoprotein (Pgp) couples drug transport to ATP hydrolysis. Previously, using a synthetic library of tetramethylrosamine ( TMR) analogues, we observed significant variation in ATPase stimulation ( V m (D)). Concentrations required for half-maximal ATPase stimulation ( K m (D)) correlated with ATP hydrolysis transition-state stabilization and ATP occlusion (EC 50 (D)) at a single site. Herein, we characterize several TMR analogues that elicit modest turnover ( k cat <or= 1-2 s (-1)) compared to verapamil (VER) ( k cat approximately 10 s (-1)). Apparent ATPase activities manifest as nearly equivalent to basal values. In some cases, K m (D) parameters for drug stimulation of ATPase could not be accurately determined, yet these same TMR analogues promoted ATP occlusion at relatively low concentrations ( approximately 0.4-40 microM). Moreover, the TMR analogues competitively inhibited VER-dependent ATPase activity at concentrations similar to those required for ATP occlusion. Finally, the TMR analogues facilitated uptake of calcein-AM into CR1R12 and MDCK-MDR1 cells and are actively transported by Pgp in monolayers of MDCK-MDR1 cells at similarly low concentrations ( approximately 1-20 microM). ADP.V i release kinetics were identical in the presence of the TMR derivatives, VER, or in the absence of drug, suggesting that slow turnover is not likely due to slow release of the ATP hydrolysis products ADP and P i. These data support the partition model in which drug site occupancy converts residual basal ATPase activity to a drug-dependent mechanism even in cases where stimulation appears to be exactly compensatory to basal values. It is noteworthy that when compared to previously reported TMR analogues, subtle modification of the TMR scaffold can confer large differences in ATP turnover.
Photochemistry and Photobiology | 2006
Stephen J. Wagner; Andrey Skripchenko; Dedeene Thompson-Montgomery; Helen Awatefe; David J. Donnelly; Michael R. Detty
Abstract The efficacy of two chalcogenoxanthylium photosensitizers to reduce pathogens in red cell suspensions while maintaining red cell storage properties was investigated in the presence and absence of the red cell band-3 ligand and antioxidant, dipyridamole (DP). In the presence of DP, both sensitizers, TMR-S and DJD-42, displayed potent virucidal photoactivity (>6 log10) and species-dependent bactericidal activities that ranged from 0.6 to 8.7 log10. Addition of DP to red cell suspensions containing TMR-S or DJD-42 reduced Day 42 photoinduced hemolysis by approximately eight-fold and four-fold, respectively. Red cell binding studies revealed only a small degree of competition between DP and TMR-S, and no competition between DP with DJD-42 for binding to red cell membranes, suggesting that protection of red cells by DP in this system may primarily stem from its antioxidant properties.
Journal of Physical Chemistry B | 2004
Tymish Y. Ohulchanskyy; David J. Donnelly; Michael R. Detty; Paras N. Prasad
Bioorganic & Medicinal Chemistry | 2004
Michael R. Detty; Paras N. Prasad; David J. Donnelly; Tymish Y. Ohulchanskyy; Scott L. Gibson; Russell Hilf
Organometallics | 2007
Brandon D. Calitree; David J. Donnelly; Jason J. Holt; Michael K. Gannon; Cara L. Nygren; Dinesh K. Sukumaran; Jochen Autschbach; Michael R. Detty
Bioorganic & Medicinal Chemistry | 2005
Stephen J. Wagner; Andrey Skripchenko; David J. Donnelly; Krishna Ramaswamy; Michael R. Detty
Bioorganic & Medicinal Chemistry | 2005
Scott L. Gibson; Jason J. Holt; Mao Ye; David J. Donnelly; Tymish Y. Ohulchanskyy; Youngjae You; Michael R. Detty
Organometallics | 2005
David J. Del Valle; David J. Donnelly; Jason J. Holt; Michael R. Detty
Journal of Organic Chemistry | 2003
Nancy K. Brennan; David J. Donnelly; Michael R. Detty
Bioorganic & Medicinal Chemistry | 2004
Scott L. Gibson; Russell Hilf; David J. Donnelly; Michael R. Detty